| CALPAIN INHIBITOR PEPTIDE |
ASP-PRO-MET-SER-SER-THR-TYR-ILE-GLU-GLU-LEU-GLY-LYS-ARG-GLU-VAL-THR-ILE-PRO-PRO-LYS-TYR-ARG-GLU-LEU-LEU-ALA |
128578-18-7 |
| RO-31-8425 |
3-[8-(氨基甲基)-6,7,8,9-四氢吡啶并[1,2-A]吲哚-10-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
131848-97-0 |
| KT5823 |
蛋白激酶仰制剂KT5823 |
126643-37-6 |
| 6-[8(Z),11(Z),14-PENTADCATRIENYL] SALICYLIC ACID |
鄰十五碳二烯柳酸 |
126633-45-2 |
| 15(S)-HPEPE |
15(S)-HPEPE |
125992-60-1 |
| SAMS PEPTIDE |
HIS-MET-ARG-SER-ALA-MET-SER-GLY-LEU-HIS-LEU-VAL-LYS-ARG-ARG |
125911-68-4 |
| TCN 238 |
TCN 238 |
125404-04-8 |
| 1-O-(15-carboxypentadecyl)-2-O-acetylglycero-3-phosphorylcholine |
1-O-(15-carboxypentadecyl)-2-O-acetylglycero-3-phosphorylcholine |
129879-41-0 |
| RO 31-8220 METHANESULFONATE |
1G,10G,100G,1KG |
125314-64-9 |
| 5S-12R-DIHYDROXY-6Z,8E,10E,14Z-EICOSATETRAENOIC-6,7,14,15-D4 ACID |
5S-12R-DIHYDROXY-6Z,8E,10E,14Z-EICOSATETRAENOIC-6,7,14,15-D4 ACID |
124629-74-9 |
| 7-[(1S,2R,3R,4R)-3-[(1E,3R)-3-HYDROXY-4-(4-IODOPHENOXY)-1-BUTENYL]-7-OXABICYCLO[2.2.1]HEPT-2-YL]-5Z-HEPTENOIC ACID |
7-[(1S,2R,3R,4R)-3-[(1E,3R)-3-HYDROXY-4-(4-IODOPHENOXY)-1-BUTENYL]-7-OXABICYCLO[2.2.1]HEPT-2-YL]-5Z-HEPTENOIC ACID |
128719-90-4 |
| 2-Hydroxypropyl-β-cyclodextrin |
羟丙基-BETA-环糊精 |
128446-35-5 |
| N-(2-AMINOETHYL)-5-(3-FLUOROPHENYL)-4-THIAZOLECARBOXAMIDE HYDROCHLORIDE |
127917-66-2 |
127917-66-2 |
| C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT) |
NATRIURETIC PEPTIDE, C-TYPE;CNP |
127869-51-6 |
| ARVANIL |
ARVANIL |
128007-31-8 |
| HUMAN VEGF165 |
血管内皮生长因子 |
127464-60-2 |
| CGP 35348 |
(3-氨丙基)(二乙氧基甲基)膦酸水合物 |
123690-79-9 |
| N-[(3S,4R)-6-CYANO-3,4-DIHYDRO-3-HYDROXY-2,2-DIMETHYL-2H-1-BENZOPYRAN-4-YL]-N-HYDROXYACETAMIDE |
Y-26763 |
127408-31-5 |
| ceramide kinase |
ceramide kinase |
123175-68-8 |
| (+)-XESTOSPONGIN B |
(+)-XESTOSPONGIN B |
123000-02-2 |
